| 标题 |
 ASCENT-04/KEYNOTE-D19: phase 3 study of sacituzumab govitecan (SG) plus pembrolizumab (pembro) vs treatment of physician's choice (TPC) plus pembro in 1L programmed death-ligand 1-positive (PDL1+) metastatic triple-negative breast cancer (mTNBC) |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 | 暂无链接，等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)
wwww
茂茂
于林凯
东方元语
Nole
cdercder
Dean
xing_xing
馆长
Maestro_S
aajhajkahna
学术文献互助
sagitar
安详香旋
奔跑
初景
七听
Criminology34
猪猪hero
onlyone
aaaa
OK
皖公网安备34019202002308
